Cargando…
Phase I Neoadjuvant Study of Intravesical Recombinant Fowlpox-GM-CSF (rF-GMCSF) or Fowlpox-TRICOM (rF-TRICOM) in Patients with Bladder Carcinoma
Intravesical BCG is a highly effective treatment for high-grade non-muscle invasive bladder cancer and carcinoma in situ (CIS); however, for patients who are either resistant or become unresponsive to BCG therapy there is a need for alternative treatment approaches. This study examined the safety an...
Autores principales: | Portal, Daniella E., Weiss, Robert E., Wojtowicz, Malgorzata, Mansour, Amal, Monken, Claude, Mehnert, Janice M., Aisner, Joseph A., Kane, Michael, Nishioka, Jennifer, Aisner, Seena, Peters, Stephen, Stein, Mark N., Kim, Isaac Y., Mayer, Tina M., Shih, Weichung, Gulley, James, Streicher, Howard, Singer, Eric A., Lattime, Edmund C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923616/ https://www.ncbi.nlm.nih.gov/pubmed/31222182 http://dx.doi.org/10.1038/s41417-019-0112-z |
Ejemplares similares
-
Impact of age on antigen-specific T lymphocyte response in patients treated with PSA-TRICOM
por: Singh, Harpreet, et al.
Publicado: (2014) -
MVA-brachyury Tricom vaccine/pembrolizumab: Various toxicities: case report
Publicado: (2021) -
Digital immunohistochemistry analysis of intratumoral immune infiltrates in prostate cancer patients treated with intraprostatic/systemic PSA-TRICOM vaccine
por: Farsaci, Benedetto, et al.
Publicado: (2013) -
THE INFLUENCE OF PH AND OSMOLALITY ON FIXATION OF THE FOWLPOX VIRUS CORE
por: Hyde, James M., et al.
Publicado: (1970) -
Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
por: Heery, Christopher R, et al.
Publicado: (2015)